MARKET

PHIO

PHIO

Phio Pharmaceuticals Corp
NASDAQ
1.360
-0.010
-0.73%
Pre Market: 1.430 +0.07 +5.15% 08:03 09/27 EDT
OPEN
1.360
PREV CLOSE
1.370
HIGH
1.400
LOW
1.350
VOLUME
329
TURNOVER
--
52 WEEK HIGH
12.27
52 WEEK LOW
1.330
MARKET CAP
3.02M
P/E (TTM)
-0.1338
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at PHIO last week (0918-0922)?
Weekly Report · 2d ago
Weekly Report: what happened at PHIO last week (0911-0915)?
Weekly Report · 09/18 10:15
Weekly Report: what happened at PHIO last week (0904-0908)?
Weekly Report · 09/11 10:14
Weekly Report: what happened at PHIO last week (0828-0901)?
Weekly Report · 09/04 18:42
Weekly Report: what happened at PHIO last week (0821-0825)?
Weekly Report · 08/28 10:17
HC Wainwright & Co. Reiterates Buy on Phio Pharma, Maintains $6 Price Target
Benzinga · 08/16 10:37
H.C. Wainwright Sticks to Its Buy Rating for Phio Pharmaceuticals (PHIO)
TipRanks · 08/16 10:25
Phio Pharmaceuticals Corp: Quarterly report
Press release · 08/10 22:41
More
About PHIO
Phio Pharmaceuticals Corp. is a clinical-stage biotechnology company. The Company is focused on developing immuno-oncology therapeutics based on its self-delivering ribonucleic acid interface (RNAi) INTASYL therapeutic platform. Its INTASYL compounds are designed to precisely target specific proteins that reduce the body’s ability to fight cancer without the need for specialized formulations or drug delivery systems, and are designed to make immune cells effective in killing tumor cells. Its lead product candidate, PH-762, is an INTASYL compound designed to reduce the expression of cell death protein 1 (PD-1). PD-1 is a protein that inhibits T cells’ ability to kill cancer cells and is a clinically validated target in immunotherapy. Its second product candidate, PH-894, is an INTASYL compound that is designed to silence BRD4, a protein that controls gene expression in both T cells and tumor cells, thereby effecting the immune system as well as the tumor.

Webull offers kinds of Phio Pharmaceuticals Corp stock information, including NASDAQ:PHIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHIO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PHIO stock methods without spending real money on the virtual paper trading platform.